12.13.17 It’s spelled out in our mission. MOCA works to advance ovarian cancer research towards early diagnosis.
We have provided more than $7 million to Minnesota researchers focused on ovarian cancer. But we wanted to expand our reach to spur on researchers committed to developing an early detection test for ovarian cancer.
That’s why, for the first time ever, we provided the inaugural grant funding of MOCA’s new National Early Detection Research Awards.
We’ve provided funding to two researchers focused on promising early detection test research:
- Kevin Elias, MD, of Harvard Medical School, Boston. “Phase 3 validation of a serum miRNA neural network for the early detection of ovarian cancer.” $50,000 for one year.
- Barbara Norquist, MD of the University of Washington, Seattle. “Detection of ovarian cancer by uterine lavage with Crispr-Duplex sequencing.” $50,000 for one year.
In the coming weeks, stay tuned for profiles on each researcher and details on their projects.
We are proud to be awarding these new grants – and we are proud of the fact that your contributions have made MOCA one of the top private funders of ovarian cancer research in the nation.
But we can’t do this vital work without your help.
This holiday season, please consider a tax-deductible gift to MOCA. Your gift will help MOCA continue the life-saving research that will discover an early detection test.
When detected early, 70% of women can be cured of ovarian cancer. But fewer than 20% of ovarian cancers are detected early.
Let’s work together to change this. MOCA is committed to funding research focused on an early detection test. Your gift will help make this possible.